Pappas Capital

Profile

Pappas Capital is a global venture capital and commercial development firm specializing in next-generation life science, agriculture, and technology companies. Based in the United States, the firm was founded over 32 years ago and has invested in more than 100 companies across North America and Asia. The team is comprised of experienced investment professionals who provide insight and guidance across their portfolio, leveraging a deep understanding of the drug development process and a strong industry network.

Pappas Capital operates through three primary initiatives: Pappas Ventures, which focuses on life science ventures; Specialized Fund Management, which manages custom investment vehicles; and Translational Medicine, which partners with research universities to advance scientific discoveries. The firm targets investments in sectors such as Life Sciences, HealthTech, and AgTech, among others, typically focusing on early to late-stage companies. The firm's typical investment size ranges from $1-5 million to $10-50 million.

Notable investments from Pappas Capital include companies like Minoryx Therapeutics, which focuses on rare neurodegenerative diseases. Through strategic partnerships, Pappas Capital supports its portfolio companies in finding talent and crafting regulatory strategies, endeavoring to accelerate their progress with the help of an extensive professional network.